DELIVERING HEALTH INFORMATION
YOU CAN TRUST SINCE 1989
Join the enews community - Terms
MEMBER
MENU
Filter by Categories
Blog
General
Lifestyle

Covid-19 “a huge commercial opportunity”, says Pfizer

Reading time: 2 minutes

The US government has placed a $1.95bn order for 100 million doses of the vaccine – but it’s all contingent on the vaccine working. If it does, Pfizer is set for “a windfall” of $15bn, drug industry watchers predict.

But revenues could be double that if Pfizer progresses with its plans for a two-shot Covid vaccine, which its researchers are currently working on. The two-dose shot will cost $39.

US agencies are set to place an order for 500 million doses if the vaccine can be proven to work, and regulators will be setting the bar low to get a vaccine on the market as quickly as possible. The usual safety tests will be by-passed as those may take years of monitoring.

It’s all great news for Pfizer shareholders, says industry analyst Randall Stanicky of RBC Capital Markets. The company’s CEO, Albert Bourla, agrees. In a recent online conference, he said the virus presented “a huge commercial opportunity”.

Pfizer isn’t the only one in the race, hoping for massive revenue boosts, of course. Unusually, it hasn’t sought government funding to help support its research for a vaccine, but those that have will be charging far less. AstraZeneca, for instance, is expected to charge around $4 per dose in recognition of government aid, and this is reckoned to be an ‘at-cost’ price with almost no profit added in.

Pfizer has set the price of a Covid shot, and especially for manufacturers who have funded their own research. Another vaccine front-runner, Moderna, was predicted to set its per-shot price at $50, but is now expected to fall in line with the Pfizer price.

Read all about it – but only in WDDTY

From now on, you won’t be able to buy WDDTY in a store, as we are reverting to a subscription-only magazine. The reason goes to the very heart of what this publication stands for. As a newsstand title, we were being censored in all sorts of subtle and not-so-subtle ways by a retail trade that chose never to support press freedoms. But we don’t want to stop you from getting vital information which is why we’ve curated this special subscription offer just for you. By subscribing you can still get direct access to all this information every month, via a subscription, as thousands of others do.

(Source: Fiercepharma.com, July 27, 2020)

What do you think? Start a conversation over on the... WDDTY Community

Article Topics: dose, vaccine
  • Recent Posts

  • Copyright © 1989 - 2026 WDDTY
    Publishing Registered Office Address: The Landing, Tileman House, 131 Upper Richmond Rd, London SW15 2TL
    Skip to content